Patterns of longitudinal change in hepatitis C virus neutralization titers correlate with the outcome of peginterferon and ribavirin combination therapy
- 4 February 2015
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 87 (5) , 821-828
Abstract
In chronic hepatitis C virus (HCV) infection, combination therapy of peginterferon and ribavirin does not guarantee viral eradication. Among factors relevant to therapeutic efficacy, the role of humoral immunity has not been examined thoroughly. In the current study, HCV pseudoparticles (HCVpp) were first generated with 80 patient-derived full-length HCV envelope clones, followed by detailed characterization with regard to virus productivity, infectivity and neutralizing activity. Selective HCVpp were used to measure HCV neutralization titers in two independent patient cohorts consisting of 102 patients undergoing antiviral therapy. The HCV neutralization titers at the baseline fitted with a power-law distribution among patients. Pretreatment neutralization titers in both patient cohorts were not correlated with treatment outcomes. In the patient cohort 2 (n = 28) that had samples available at multiple time points, however, HCV neutralization titers displayed clearly distinct patterns over therapeutic course and follow-up. No virological responders (n = 10) had neutralization titers stabilized at low level while it was increased significantly in both sustained virological responders (n = 10) and relapsers (n = 8). High HCV neutralization titers were maintained only in sustained virological responders but not in relapsers after treatment cessation. Therefore, patterns of longitudinal change of HCV neutralization titers, but not pretreatment titers, correlate with the treatment outcome in patients undergoing peginterferon and ribavirin combination therapy. J. Med. Virol. 87:821–828, 2015.Keywords
Funding Information
- National Institutes of Health (DK80711)
This publication has 25 references indexed in Scilit:
- The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010Journal of Hepatology, 2014
- Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infectionVirology, 2013
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationJournal of Experimental Medicine, 2010
- High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy†Hepatology, 2009
- Power-Law Distributions in Empirical DataSIAM Review, 2009
- Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C VirusGastroenterology, 2009
- Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis CGut, 2007
- Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirinJournal of Clinical Virology, 2007
- Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral InfectionGastroenterology, 2005
- Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus InfectionJournal of Virology, 2005